Use of elexacaftor+tezacaftor+ivacaftor in individuals with cystic fibrosis and at least one F508del allele: a systematic review and meta-analysis.
Luiz Vicente Ribeiro Ferreira da Silva-FilhoRodrigo Abensur AthanazioCarolina Rodrigues TononJuliana Carvalho FerreiraSuzana Erico TanniPublished in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (2024)
Our findings demonstrate that ETI treatment substantially improves clinically significant, patient-centered outcomes.